Functional neurological disorders as seen by a cohort of general practitioners in Northern Italy: evidence from an online survey by Marotta, Angela et al.
ORIGINAL RESEARCH
published: 25 January 2021
doi: 10.3389/fneur.2021.583672
Frontiers in Neurology | www.frontiersin.org 1 January 2021 | Volume 12 | Article 583672
Edited by:
Laura Avanzino,
University of Genoa, Italy
Reviewed by:
Davide Martino,
University of Calgary, Canada
Alessandro Tessitore,








This article was submitted to
Neuroepidemiology,
a section of the journal
Frontiers in Neurology
Received: 16 July 2020
Accepted: 04 January 2021
Published: 25 January 2021
Citation:
Marotta A, Fiorio M, Fracasso I,
Franchini CA, Defazio G and Tinazzi M
(2021) Functional Neurological
Disorders as Seen by a Cohort of
General Practitioners in Northern Italy:
Evidence From an Online Survey.
Front. Neurol. 12:583672.
doi: 10.3389/fneur.2021.583672
Functional Neurological Disorders as
Seen by a Cohort of General
Practitioners in Northern Italy:
Evidence From an Online Survey
Angela Marotta 1*, Mirta Fiorio 1, Isabella Fracasso 2, Carlo Andrea Franchini 2,
Giovanni Defazio 3 and Michele Tinazzi 1*
1Department of Neurosciences, Biomedicine and Movement Sciences, Università di Verona, Verona, Italy, 2 Italian Society of
General Practice and Primary Care (SIMG)–Section of Verona, Verona, Italy, 3Neurology Unit, Department of Medical
Sciences and Public Health, University of Cagliari and AOU Cagliari, Cagliari, Italy
General practitioners (GPs) provide primary care and advise their patients on which
diagnostic and therapeutic pathways they judge most appropriate. For patients with
functional neurological disorders (FND), receiving a proper explanation of diagnosis by
their GP from the very beginning may drastically improve prognosis. Novel approaches
to the diagnosis and treatment of FND have important implications for effective
management. The aim of this study was to investigate Italian GP opinion and knowledge
about FND in light of new approaches to the illness. To do this, we evaluated the
responses to a 13-item web-based survey completed by 133 GPs practicing in northern
Italy. Psychological terms to describe FND were more frequently used than functional
neurological disorder and mental illness was considered an important predictor of
diagnosis. Referral to a neurologist rather than to a psychiatrist was largely preferred,
while physiotherapy consultation was seldom recognized as a valuable approach
to treating FND. Overall, the survey findings suggest that knowledge about novel
approaches to FND is somewhat lacking. Currently, GPs appear to be transitioning from
a classical psychological view of the disorder toward a more modern conceptualization,
in which neurobiological, psychological, and social factors all play an important role.
Professional education during this transition would be an advantageous way to optimize
physician management of FND and to enhance diagnosis, explanation, andmanagement
across primary and secondary care pathways.
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INTRODUCTION
General practitioners (GPs) often encounter patients presenting with symptoms unexplained
by organic damage (1). In patients with functional neurological disorders (FND) for example,
symptoms are characterized by clinical signs outside the normal rules of neurological disease
(2). Common presentations are functional movement disorders and dissociative seizures. The
functional movement disorders present with motor symptoms (e.g., tremor, dystonia, gait
abnormalities) that may disappear or subside with distraction. Dissociative seizures resemble
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epileptic seizures or syncope without abnormal electrical brain
activity (3). Due to unclear diagnosis and management, patients
with FNDmay receive the wrong diagnosis or a poor explanation
of their medical condition, resulting in misunderstanding and
leading to inappropriate treatment and poor outcome (4).
Our understanding of FND has made considerable advances,
with implications for diagnosis and treatment. Research into
the pathophysiology of FND has challenged old assumptions
about the disease as a primarily psychological illness (5). It has
been widely demonstrated that symptoms are more consistently
explained by abnormalities in high-order cognitive functions
involving attention and sense of agency (e.g., feeling of control
over abnormal bodily movement) rather than by psychological
difficulties (6). The development of novel approaches to the
diagnosis and treatment of FND has gone forward with
this modern conceptualization of the disease. Positive clinical
signs have been clearly identified that distinguish functional
neurological symptoms from their organic counterpart (e.g.,
functional tremor but not organic tremor is modified by
distractive maneuvers) (4). Recent FND management guidelines
recommend a multidisciplinary stepped approach in which care
is delivered by a coordinated specialist team (e.g., neurologist,
psychiatrist, physiotherapist, psychotherapist) (7). In addition, a
growing body of evidence suggests that such approaches improve
the efficacy of managing FND (4, 8–10).
Nonetheless, many health care professionals, including GPs,
find FND difficult to manage (3, 11). Studies across different
countries investigating the opinions and clinical experience
of health care providers [e.g., (3, 12–18)] have revealed that
poor knowledge about novel approaches to FND diagnosis
and treatment might explain at least in part the difficulties
in dealing with FND. The studies involved mainly specialists
(e.g., neurologists, psychiatrists, psychologists, physiotherapist)
and left almost completely unexplored the opinions and clinical
experience of GPs - the primary providers of health care.
Exploring GP attitudes toward FND deserves particular
attention since they play a pivotal role in health care (7).
They are the initial contact with the national health system.
As such, they act as gatekeepers to accessing most secondary
and specialist care, besides providing patients with a clear
explanation of their symptoms from the very beginning.
Moreover, because they are familiar with their patients’
medical history, they can consult with specialists for making
informed decisions. Finally, they can support management
of the disease by ensuring continuity and coordination of
care in the community (19) and help patients understand
the diagnosis, thus increasing the chances for adherence
to therapy and for favorable outcome (20). Despite their
potential role in improving primary care for FND, little is
known about the opinions and clinical experiences of GPs
regarding FND.
With this exploratory study we investigated the opinion,
knowledge, and clinical experience of a cohort of Italian GPs
regarding FND. To do this, we developed an ad hoc online survey.
The items were focused on areas (terminology, diagnosis, and
management strategies) that have been consistently reworked
in light of the novel approach to FND. We also explored GP
attitudes toward FND, their role in diagnosis and treatment, and
their interest in improving their understanding of the disease.
MATERIALS AND METHODS
The findings of this ad hoc quantitative exploratory web-based
cross-sectional survey are reported according to the Checklist for
Reporting Results of Internet E-Surveys (CHERRIES) guidelines
(21) and to STrengthening the Reporting of OBservational
Studies in Epidemiology (STROBE) (22). An initial literature
review was conducted to assess previous studies examining
the opinion, knowledge, and clinical experience of health care
professionals with medical conditions that are not explained
by organic damage. Based on these studies (3, 12, 23, 24), we
created a preliminary questionnaire, which was then modified
according to the feedback from two GPs (CAF, IF). The final
13-item questionnaire version is divided into three sections as
described below.
Section 1: Demographic and professional characteristics. Four
items investigated demographic (age, sex) and professional
characteristics (number of years practiced as GP and number
of patients).
Section 2: Opinion, knowledge, and clinical experience. The
first of seven items investigated exposure to FND (i.e., number
of patients that GPs believe have symptoms not explained by an
organic cause). The second was a multiple-choice question about
the terms used to name FND. The third focused on predictors
of diagnosis. The respondents rated the extent to which they felt
certain criteria were predictive for a diagnosis of FND as “not
predictive at all,” “not very predictive,” “somewhat predictive,”
“very predictive,” “extremely predictive,” or “I don’t know.” The
fourth item investigated opinions about the adequacy of specialist
consultation/treatment. The respondents rated the degree of
adequacy (i.e., “not adequate at all”, “not very adequate”, “partly
adequate”, “very adequate”, or “highly adequate,” and “I don’t
know”) of four specialist consultations and five types of treatment
for FND. The fifth regarded the management strategies the
respondents used to deal with their patients. The respondents
stated the extent to which they agreed (“strongly disagree,”
“disagree,” “uncertain,” “agree,” “strongly agree”) with options for
initial intervention in FND. The sixth item was a multiple-choice
question on the role of GPs in FND diagnosis and treatment.
The final item investigated the level of satisfaction on an 11-point
scale from 0 (no satisfaction) to 10 (high satisfaction) in dealing
with patients with FND. The items in this section are reported in
Supplementary Table 1.
Section 3: Interest in FND. The third section consisted of two
dichotomic items investigating interest in FND.
Data Collection
GPs were recruited from the members of two Italian GP societies:
the Italian Society of General Practice and Primary Care (SIMG)
– Section of Verona, and the Federazione Italiana Medici di
Medicina Generale (FIMMG). Only society members practicing
in Verona were invited to take part at the survey. The Google
Forms online tool was used (Google LLC,Menlo Park, CA, USA).
Data were collected over a 18-weeks period (30 October 2017–7
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March 2018). An e-mail from theVerona chapter of SIMG (SIMG
-Verona) inviting participation in the study was sent to the 397
SIMG and FIMMG members practicing in Verona. The e-mail
explained that the study investigated GP opinions, knowledge,
and clinical experience with non-organic neurological disorders.
The neutral term non organic was used to avoid connotations
with presumed pathophysiological mechanisms underlying the
disease (i.e., “functional” or “psychological”). An example of what
we meant by a “non-organic” neurological disorder (neurological
symptoms, like tremor, that may disappear with distraction)
was also given to exclude potential bias due to misleading
terminology. The invitation contained the survey link, and
personal data handling (anonymity). Also, GPs were informed
that the survey took about 5min to complete. Four e-mail
reminders were sent by SIMG at 2, 4, 8, 12, and 16 weeks after
the initial mailing. Response to all survey items was mandatory.
If a response to an item was missed, an alert appeared on the
screen and the respondent had to respond to the item in order
to proceed to the next one. The study was approved by the ethics
committee of the University of Verona and was conducted in
accordance with the Declaration of Helsinki. Response to the
survey was assumed to grant consent (23).
Data Analyses
Data were downloaded from the Google Forms onto Excel sheets
and reviewed for accuracy. Analysis was performed using SPSS
software (version 19). Responses were analyzed with descriptive
statistics, expressed as the mean (±standard deviation [SD]) and
percentage for continuous and categorical variables, respectively.
Data from Section 2 were analyzed in depth after converting
responses to predictors of diagnosis, specialist consultation,
treatment adequacy for FND, and management strategies into
a 5-point Likert scale from 1 (“not predictive at all,” “not
adequate at all,” and “strongly disagree”) to 5 (“extremely
predictive,” “extremely adequate,” and “strongly agree”). The
distribution average of the responses to each item (i.e., predictors
of diagnosis, perceived usefulness of consultations/treatments,
GP management strategies) was compared using the Wilcoxon
signed-rank test. Spearman’s correlations were performed to
investigate potential correlations between respondent age and
years of medical practice. The difference in the number of
male and female GPs was analyzed using the chi-squared test.
Statistical significance was set at p < 0.05.
RESULTS
Section 1: Demographics and Professional
Characteristics
The overall response rate was 39% (n = 133). Most respondents
were men (n = 82, 62%) (chi-squared 7.22, p = 0.007) and >51
years old (n = 104, 78%) (mean age ± SD, 57 ± 9.01). The
majority had been practicing for more than 20 years (n = 88,
66%) (mean years practiced, 24.02 ± 12.48), with a catchment
area of more than 1,000 patients (n= 121, 91%) (Table 1).


















Section 2: Opinion, Knowledge, and
Clinical Experience
Exposure to FND
For the item “In your opinion, how many of your patients might
present with neurological symptoms without an organic cause?”
the majority (n = 78, 59%) reported they believe that <10% of
their patients might present neurological symptoms without an
organic cause. Many (n= 42, 32%) estimated a higher proportion
of these disorders among their patients (10–25%). Few (n =
8, 6%) believed that 25–50% of their patients were likely to be
affected by FND, while none reported that more than half of their
patients might have FND. Very few were unable to estimate how
many of their patients might have FND (n= 5, 4%) (Table 2).
Terminology
Respondents could choose from a list of 10 terms they usually
used to describe neurological symptoms without an organic
cause. More than one response was allowed for this item. A
total of 259 responses were collected, including the free-text
responses (n = 6), with the majority of respondents (n = 79,
60%) selecting more than one response. “Functional neurological
disorders” (n = 71/259, 27%) and “Somatization disorder” (n =
58/259, 23%) were the two most frequent responses (Table 2).
The term “Functional neurological disorders” was selected 30
times alone and 41 times together with “Conversion disorder” (n
= 3), “Somatization disorders” (n = 21), “Depression” (n = 6),
“Unspecific anxious syndrome” (n = 9), “Psychogenic disorder”
(n = 9), “Medically unexplained syndrome” (n = 1), “Non
organic neurological disorder” (n= 12). The term “Somatization
disorder” was selected 9 times alone and 49 times together
with “Functional neurological disorders” (n = 21), “Conversion
disorder” (n = 3), “Depression” (n = 15), “Unspecific anxious
syndrome” (n = 21), “Stress related disorder” (n = 20),
“Psychogenic disorder” (n = 8), and “Non organic neurological
disorder” (n= 5).
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TABLE 2 | Exposure to patients with FND and terms chosen to define the disease.





I don’t know 5 (4)
Terminology*
Functional neurological disorders 71 (27)
Somatoform disorders 58 (23)
Unspecific anxiety syndrome 31 (12)
Stress-related syndrome 24 (9)
Depression 22 (8)
Non-organic disorder 21 (8)
Psychogenic disorder 19 (7)
Conversion disorder 5 (2)
Medically unexplained disorder 2 (1)
Hysteria 0 (0)
GP, general practitioner; FND, functional neurological disorders; *More than one
response allowed.
Overall, psychology-related terms (e.g., “Somatization
disorder,” “Unspecific anxious syndrome,” “Stress-related
syndrome,” “Psychogenic disorder,” “Conversion disorder”)
were selected more often (n = 159/259, 61%) than the novel
term “Functional neurological disorders” (n = 71/259, 27%),
indicating that a psychological view of FND is still widely held by
this sample of GPs. Terms related to uncertain etiology (“Non-
organic disorders” and “Medically unexplained disorders”) were
less often selected (n = 23/259, 9%) (Figure 1), suggesting that
indefinite definitions of FND were generally unacceptable.
Finally, free-text responses were included to capture any
other terms in use; for example: symptom description (n = 2),
intentional tremor (n = 1), fibromyalgia (n = 1), neurological
disease under assessment (n = 1), cognitive deficit due to side
effect of statins in patients with genetic predisposition (n= 1).
Predictors of Diagnosis
When asked to judge the extent to which certain diagnostic
criteria were predictive for FND (from “not predictive at
all” to “extremely predictive”) (Supplementary Table 2), on
average, respondents rated “Extensive normal or inconclusive
neurological examination” (3.86± 1.03), “Previousmental illness
or psychological stress” (3.71 ± 0.98), and “Excessive loss of
function or disability relative to examination findings” (3.48 ±
0.92) higher than “Spontaneous remissions” (3.40 ± 0.97) and
“Other medically unexplained symptoms” (3.38 ± 0.82) (all p <
0.01). “Litigation” was rated lowest among all options (2.72 ±
1.15) (all, p< 0.001): either “not predictive at all” (n= 23) or “not
very predictive” (n= 21) (Figure 2). The degree of predictivity of
the diagnostic criteria did not correlate with age (all, p > 0.09) or
years of practice (all, p > 0.10).
Specialist Consultation
When asked to judge the extent to which certain specialist
consultations were adequate for FND (from “not adequate
at all” to “extremely adequate”) (Supplementary Table 3), the
respondents rated “Neurological consultation” (3.57 ± 0.97)
highest among all options (all p < 0.038). “Psychotherapy
consultation” (3.31± 1.03) was rated higher than “Physiotherapy
consultation” (2.92 ± 1.00) (Z = −3.26, p = 0.01). “Psychiatric
consultation” (3.12 ± 0.96) was rated equally adequate for FND
as both “Psychotherapy consultation” (Z = −1.85, p = 0.06) and
“Physiotherapy consultation” (Z=−1.46, p= 0.14) (Figure 3A).
These results did not correlate with age (all, p > 0.30) or years of
practice (p > 0.21).
Treatment
When the GPs were asked to indicate the degree of adequacy
of five different treatments for FND (from “not adequate
at all” to “extremely adequate”) (Supplementary Table 3), on
average, their responses did not statistically differ for degree of
adequacy of “Rehabilitation (e.g., biofeedback, physiotherapy)”
(3.40 ± 0.99), “Educational interventions” (3.36 ± 0.99), and
“Psychotherapy with antidepressant or anxiolytic medications”
(3.22± 0.91) (all p > 0.07), suggesting that they believed them to
be equally adequate for treating FND. Moreover, “Psychotherapy
without antidepressant or anxiolytic medications” (3.16 ±
0.80) was rated lower than “Rehabilitation” (Z = −2.42, p =
0.02) and “Educational interventions” (Z = −2.07, p = 0.04).
Finally, “Pharmacological treatment” (2.89 ± 0.79) was rated
lowest among all treatments (all p < 0.03), indicating that the
pharmacological approach was judged the least adequate for
treating FND (Figure 3B). Age significantly correlated with the
degree of adequacy of “Psychotherapy without antidepressant or
anxiolytic medication” for FND (r=−0.19, p= 0.03), suggesting
that the younger the respondent, the higher that psychotherapy
without pharmacological treatment was judged adequate for
treating FND. Significant correlations were also found between
years of practice and two treatments: “Psychotherapy without
antidepressant or anxiolytic medication” (r = −0.21, p = 0.02)
and “Rehabilitation services” (r = −0.21, p = 0.02), indicating
that the fewer the years of practice, the higher the adequacy of
these two treatments was rated.
Management Strategies
When asked to indicate their level of agreement (from “extremely
disagree” to “extremely agree”) with management strategies
that they would adopt as a first step when dealing with FND
(Supplementary Table 4), the respondents were equally oriented
toward: “Wait to see how symptoms develop” (3.47 ± 1.00),
“Referral to a neurologist” (3.44 ± 1.05), and “Instrumental
examination” (3.31 ± 0.95) (all, p > 0.208). These interventions
were more often selected than “Referral to a psychiatrist (2.83
± 0.96), “Pharmacological prescription” (2.73 ± 0.87), and
“Referral to another specialist” (2.19 ± 0.90) (all p < 0.001).
“Referral to a psychiatrist” and “Pharmacological prescription” (p
= 0.435) were rated higher than “Referral to another specialist”
(all p < 0.001) (Figure 4). The degree of agreement with the
management strategies did not correlate with age (all, r < 0.08,
p > 0.188) or years of practice (all, r < 0.09, p > 0.283).
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FIGURE 1 | Number and percentage of preference for terms used to refer to symptoms not explained by organic damage. The group of psychology-related terms
received more responses than the more appropriate term functional neurological disorder, while the terms suggesting an undefined etiology were least often selected.
FIGURE 2 | Average rating for predictors of the diagnosis of FND. The higher the score, the higher the degree of predictivity. Asterisks show significant differences.
Error bars represent standard errors.
Satisfaction
When asked to rate the degree of satisfaction in managing FND
on an 11-point scale from 0 (not at all) to 10 (extremely satisfied),
on average, the respondents stated they were satisfied with how
they dealt with FND (5.48 ± 2.16). The majority (n = 93, 70%)
rated their level of satisfaction between 5 and 10. The satisfaction
level did not correlate with age (r =−0.09, p= 0.28) and years of
practice (r =−0.12, p= 0.15).
The Role of GPs
When asked about their role in the management of FND, the
majority (n = 94, 71%) gave more than one response, with
“Following-up the treatment together with the specialist who
delivered the diagnoses” (n = 97, 73%) the most frequent
one; “Make the diagnosis and recommend the most adequate
treatment” (n = 67, 50%) and “Educational intervention for
patients and their families” (n = 51, 38%) were also frequently
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FIGURE 3 | Average ratings for specialist consultation (A) and treatment (B). The higher the score, the higher the specialist consultation/treatment was rated
adequate for FND. Asterisks show significant differences. Error bars represent standard errors.
given. “Referral to the specialist most appropriate for the patient’s
medical condition” was selected by 32 GPs (24%). Finally, some
believed that their role was “Make the diagnosis and personally
follow-up the patient” (n= 25, 19%)” (Figure 5).
Section 3: Interest in FND
The majority in our sample were interested in improving their
knowledge of FND through access to more information (n= 119,
89%) or by taking part in professional courses on these disorders
(n= 108, 81%).
DISCUSSION
FND are associated with long-term disability, poor quality of
life, and extensive health care utilization with a huge economic
impact on the health care system (25). GPs can do their part
to improve care for patients with FND by referring them to the
most appropriate diagnostic and therapeutic pathways from the
very beginning. Yet little is known about their actual knowledge
of the novel approaches to FND diagnosis and treatment. With
this exploratory study we provide a picture of the opinions,
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FIGURE 4 | Average ratings for management strategies as the first intervention. The higher the score, the higher the agreement with the strategy. Asterisks show
significant differences. Error bars represent standard errors.
FIGURE 5 | Number and percentage of how GPs see their role in caring for patients with FND.
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knowledge, and clinical experience of a sample of Italian GPs
concerning FND in light of recent advances.
Our main findings suggest that a clear idea of FND is lacking
among GPs. Their opinions and knowledge appear to be in a
sort of limbo between a modern approach to the disorders and
outdated psychological models.
Opinions and Knowledge About FND
That the current approach to FND encompasses both modern
and classical (psychological) views of these disorders clearly
emerged when the GPs were asked about the terms they
usually adopt for symptoms without an organic cause. Use of
terminology reflects the many different ways of conceptualizing
and approaching the problem of patients with symptoms that are
unexplained by the disease (26). In our sample, the terms “non-
organic disorder” and “medically unexplained disorders” were
among the least used. They often convey diagnostic uncertainty
and the need to continue investigating for other causes (2). The
low rating for these terms is likely suggestive of the GPs’ need
for a clear explanation of the disease, with implications for a
potential reduction of unnecessary and costly diagnostic testing.
Nonetheless, a definite conceptualization of FND seems to be
missing, as suggested by the fact that the majority selected more
than one term to describe symptoms without an organic cause,
among which “Functional neurological disorder” was the most
frequently selected. This suggests that the GPs were more likely
to describe the cause of FND as a change in nervous system
function rather than structure (26). Psychology-related terms
(e.g., “Somatization disorders,” “Unspecific anxiety syndrome”)
were more frequently selected than “Functional neurological
disorder.” Previous studies demonstrated that patients with FND
often feel disbelieved or misunderstood about their condition
when health care professionals explain the disorder in terms of
psychological difficulties, which undermines patient compliance
(27). Conversely, the term “Functional neurological disorders”
is preferred by both patients and health professionals since it is
neutral with respect to the etiology of the disease, refers to the way
in which symptoms manifest, increases a patient’s understanding
and acceptance of diagnosis, and reduces the fear of social stigma
(2, 26–28). The low rate of response to “Functional neurological
disorder” may stem from less familiarity with this term compared
to psychology-related terms. Otherwise, the terminology usage
in our sample suggests that while a modern view of FND is
emerging, the classical psychological conceptualization of the
disorder is still common among GPs.
This emerged also from responses to the items about
predictors of diagnosis, specialist consultations, treatment,
and management strategies. Although the term “psychological
stressors” has been removed from the diagnostic criteria of the
Diagnostic and Statistical Manual of Mental Disorders (DSM-
5), previous mental illness or psychological stress was rated
among the most predictive criteria and often ranked as “very
predictive” or “extremely predictive.” This shows that many still
hold a psychological view of FND and lack knowledge about
new diagnostic criteria. Another observation is that litigation
was rated as the least predictive factor for a diagnosis of FND.
Since litigation has long been linked to feigned symptoms
or malingering, our results suggest that the respondents felt
patient-reported symptoms to be generally genuine and not
faked to obtain secondary gain, with implications also for
forensic medicine.
According to the most recent guidelines for FND diagnosis
(4), “Neurological consultation” was ranked as the most adequate
for FND. More respondents stated they would refer a patient
to a neurologist than to a psychiatrist as a first intervention;
this may be interpreted as less consideration given to psychiatric
connotations of the disorder and closer alignment with the
neurological approach. Moreover, referral to a psychiatrist
would require the GPs to talk with their patient about a
possible association between symptoms and psychiatric or
psychological problems. One interpretation is that GPs have
little familiarity with discussing psychological issues with their
patients, thus avoiding referral to a psychiatrist in the first
instance. Indeed, previous studies reported that many health
professionals, including GPs, often struggle with discussing
mental health problems (3). Another observation is that about
50% of the respondents selected instrumental examination as
the first management strategy, suggesting the concern to exclude
potential neurological damage. This might be related to the
GPs’ fear of missing an underlying pathological condition
related to structural damage (1). Notably, however, neurological
consultation is often sufficient per se to distinguish functional
symptoms from their organic counterpart (29), without the
need for diagnostic testing. Promoting knowledge about how
neurological assessment can provide sufficient evidence for
FND diagnosis might reassure GPs, while reducing costly and
unnecessary testing.
Psychotherapy was selected as one of the most adequate
treatments for FND, together with educational intervention
and rehabilitation (e.g., biofeedback, physiotherapy). Recent
evidence has shown the effectiveness of psychological therapy
(e.g., cognitive behavioral therapy) for seizure reduction,
improved quality of life, and better global functioning in
patients with dissociative seizures (30). Moreover, improved
outcomes have also been found with educational intervention
providing a clear explanation of the diagnosis (10). Finally,
significant improvements in functional movement disorders
have been found after multidisciplinary rehabilitation
(9) as well as physiotherapy (31–33). The results about
physiotherapy in our sample deserve special mention.
Although rehabilitation, including physiotherapy, was
rated among the most adequate treatments, physiotherapy
consultation was considered the least adequate for treating
FND. These contrasting findings might suggest that although
GPs recognize an important role for rehabilitation services
in the treatment of FND, they probably lack information
about the exact contribution that physiotherapy makes to
management of the disease. Respondent age and years of practice
correlated negatively with psychotherapy and rehabilitation
treatments. These correlations indicate that younger age
and fewer years of medical practice were associated with
recognizing the adequacy of these interventions. This might
be suggestive of more updated education about FND among
younger GPs.
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Remarkable findings also regarded the pharmacological
approach to FND, which was considered less useful compared to
rehabilitation and psychotherapy. Accordingly, pharmacological
prescription was rarely endorsed by the GPs as the first approach
to the disorder, suggesting their awareness that drug therapy is
not particularly effective.
Attitudes Toward FND
Our findings highlight that the respondents were, on average,
generally pleased with how they managed patients with FND.
The majority indicated a high level of satisfaction when
dealing with these disorders. This contrasts with evidence
from previous surveys that found negative attitudes toward
FNDs among specialists (e.g., neurologists, psychiatrists, nurses,
physiotherapists) (3, 6, 34). Moreover, the majority of our
respondents had multiple roles in managing their patients
with FND. A collaborative intervention based on cooperation
between GPs and other health care professionals was largely
preferred by our sample. This is in line with a stepped care
approach that involves diverse health professionals and is
highly recommended for managing patients with FND (7).
Furthermore, providing educational support to patients and their
family was also frequently indicated as a potential role for GPs in
the management of FND. This is encouraging, since an adequate
explanation of the diagnosis, reassurance, and education are
fundamental for the treatment of FND (29). Overall, our results
show that the GPs had a positive attitude toward FND, which is
a requisite for effective intervention. Nonetheless, the majority
expressed a need for further education about FND, likely
suggesting a perceived lack of sufficient knowledge to deal with
FND, as reported by previous surveys involving other health
professionals (3, 18, 34).
Strength and Limitations
The study findings provide a picture of the current knowledge
base, opinions, and clinical experience of a sample of Italian
GPs about novel approaches to FND. Several limitations need
to be acknowledged. The study sample was small, limiting
the generalizability of our findings. Nonetheless, the response
rate was in line with previous studies (3, 12, 24) and the
demographic and professional characteristics of the sample are
representative of the Italian GP population (35). The majority
were men over age 50, with more than 20 years of practice
and a list of more than 1,000 patients. Another limitation is
that we did not include a question about confirmed diagnoses
of FND, which limits the interpretation of our findings. In
the context, the estimate of exposure to FND might have
been biased by uncorrected diagnosis (e.g., organic disorders
diagnosed as non-organic disorders). However, our findings
are in line with epidemiological data reported elsewhere (36),
thus likely excluding a strong impact of such a bias on the
accuracy of GPs estimation. Furthermore, the short survey
items were unable to explore in depth the opinions, knowledge,
and clinical experience of the GPs. For example, asking about
“positive” findings on neurological examination (e.g., reduction
of symptoms with distractive maneuvers) would have helped to
improve our understanding of GPs knowledge about the criteria
actually used by neurologists to make a diagnosis of FND. Also,
asking whether GPs use different management strategies with
the same patients would have provided for a more in-depth
understanding of their approach to FND in clinical practice.
CONCLUSION
Our survey findings suggest that GPs need professional education
about FND. Up-to-date guidance about appropriate terminology
to use, mechanisms leading to FND, evidence-based treatments,
and stages of the stepped care approach should be provided with
the overarching aim of ensuring that patients receive consistent
diagnosis, explanation, and management across primary and
secondary care pathways. Steps in this direction have been
undertaken by the study Authors, who have conducted specialist
educational courses for GPs about the novel approach to FND
and created an illustrative leaflet about recent advances in FND.
These interventions need to be extended to a wider population of
Italian GPs in order to increase the effectiveness of primary care
for patients with FND.
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